23andMe’s Recent Research Collaborations

23andMe’s Recent Research Collaborations
Recently, 23andMe announced a collaboration with Pfizer Inc, allowing researchers with the drug maker to leverage 23andMe’s unique platform to conduct genome-wide associations studies, surveys and clinical trial recruitment. The news follows a collaboration began last summer between 23andMe and Pfizer to enroll 10,000 people in a study to explore the genetic factors associated with the onset, progression, severity and response to treatment for Inflammatory Bowel Disease.The collaboration with Pfizer — as well as work with academic researchers and other companies such as GenentechReset Therapeutics and others — is part of an effort by 23andMe to offer qualified and approved scientists outside of 23andMe a chance to leverage our unique research platform for discovery. For more about 23andMe’s collaborations see their CEO’s interview on CNBC.
Learn more and join the IBD study today: 
Subscribe or to access all post and page content.